Skip to content

Jennifer E. Cook, Director at BridgeBio Pharma, sold BBIO on Jun 24, 2026

Data as of Oct 16

▼ SELL$2.6M37,167 shares at $70.00Jennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.
Watch BBIO
Traded
Jun 24, 2026
Disclosed
Jun 24, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jennifer E. Cook, Director at BridgeBio Pharma, sold BBIO on Jun 24, 2026TRADEDDISCLOSED
BBIOSimilar stocks (XLV — its sector index fund), rebased to BBIO's price on the disclosure day
BBIO since disclosure
−4.3%
after the sale
Similar stocks (XLV) since disclosure
+15.2%
XLV — its sector index fund

Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$151Kdisclosed Jun 24 · filed 1 day after the trade

See every trade on BBIO →